SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's Laboratories ordered to pay $46.25 million to Hatchtech

16 Jun 2021 Evaluate

Dr Reddy's Laboratories has been asked to pay $ 46.25 million (around Rs 339 crore) to Australia-based Hatchtech Pty as part of an asset purchase agreement between the two parties in 2015.

The company is in receipt of an arbitration award issued by the US-based International Center for Dispute Resolution whereby a subsidiary has been asked to pay an amount of $ 46.25 million towards milestones, interest and fees to Hatchtech.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1365.60 -10.70 (-0.78%)
30-Jun-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1365.60
Cipla 1470.00
Zydus Lifesciences 1119.40
Lupin 2438.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: